Last edition
News about "BARDA "
BARDA Boosts Funding for Basilea's Investigational Oral Antibiotic Targeting Drug-Resistant UTIs
Basilea Pharmaceutica has secured an additional USD 5.4 million from BARDA to accelerate the development of its investigational oral antibiotic ceftibuten-ledaborbactam etzadroxil, a potential treatment for complicated urinary tract infections caused by multidrug-resistant Gram-negative pathogens.
BARDA | 06/08/2026 | By News Bureau
RedHill Biopharma Bags Funding Through BARDA to Advance Opaganib for Ebola Treatment
Under this cost-sharing contract, BARDA will provide partial funding for the company to further advance opaganib to mitigate infection and contain EBOV outbreaks.
BARDA | 15/10/2024 | By Aishwarya | 713
BARDA and Tiba Biotech to Develop Innovative Therapeutics Against Influenza
Tiba Biotech has joined hands with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS).
BARDA | 12/07/2024 | By Aishwarya | 612
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy